Enzo Biochem, Inc. (NYSE:ENZ) Reported Basic Consolidated EPS Of $-0.0504 For Period Ended 2015-07-31

0

The annual basic consolidated EPS for Enzo Biochem, Inc. (NYSE:ENZ) for the period ended 2015-07-31 was $-0.0504. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-07-31 was $-0.0504.

EPS from continuing operations

Coming to basic EPS from continuing operations, Enzo Biochem, Inc. (NYSE:ENZ) reported $-0.0504 for the annual period ended 2015-07-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-07-31 stood at $-0.0504.

EPS contribution from parent

For the annual period ended 2015-07-31, Enzo Biochem, Inc. (NYSE:ENZ) received basic EPS of $-0.0504 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-07-31 was $-0.0504.

Basic net EPS

For the annual period ended 2015-07-31, Enzo Biochem, Inc. (NYSE:ENZ) reported basic net EPS of $-0.05. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-07-31 stood at $-0.05.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-07-31 stood at $-0.0504. For the quarter ended 2015-07-31, consolidated diluted EPS was $-0.0504.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-0.0504 for the period ended 2015-07-31. Diluted EPS from continuing operations for the quarter ended 2015-07-31 was $-0.0504.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-07-31 was $-0.05. For the quarterly period ended 2015-07-31, net diluted EPS was $-0.05.

Diluted EPS from parent

From the parent company, Enzo Biochem, Inc. (NYSE:ENZ) received diluted EPS of $-0.0504 for the annual period ended 2015-07-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-07-31 was $-0.0504.

Enzo Biochem, Inc. (NYSE:ENZ) posted net basic EPS reading of $-0.05 for the annual period ended 2015-07-31. For the quarter, basic net EPS of $-0.05 was for the quarter ended 2015-07-31.

Net diluted EPS for Enzo Biochem, Inc. (NYSE:ENZ) for the annual period ended 2015-07-31 was $-0.05. The company also reported net diluted EPS reading of $-0.05 for the quarter ended 2015-07-31.

The annual average basic shares outstanding for the period ended 2015-07-31 is 45.355 while for the quarter ended 2015-07-31 is 45.355.

The diluted shares outstanding for the fiscal year ended is 2015-07-31 is 45.608 while for the quarter ended 2015-07-31 is 45.608.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)